Product attributes
- Place of origin: Korea
- Type of supply: Items in stock
- Condition: New
- Colour: Dark blue
- Related keywords: covid-19, SARS-COV-2, IVD, molecular diagnosis, PCR
Description by manufacturer
The PaxView SARS-CoV-2 MPCR-ULFA Kit detects the novel coronavirus, SARS-CoV-2 by using one-step RT-PCR in a single tube and a ULFA matrix detection system.
Certificates: 162872
Price: US $ 200 ~ 240 / Box
Packing and shipping
- Delivery lead time: 10 DAYS
- Minimum order: 30 Box
- Port of delivery: INCHEON AIRPORT
- HS Code: 382200
- Shipping career: DHL
Company Profile
About PaxGenBio Co., Ltd.
- Membership: Free member
- Registration date: 2021.10.23
- Country / Region: Korea
- City: Dongan-gu, Anyang-si
- Contact: Brian Lee (Sr.)
PaxGenBio Co., Ltd. was established in 2015 as a molecular diagnostics company that develops, manufactures and markets a portfolio of IVD products targeting infectious diseases and cancers.
PaxGenBio applied its patented and chimeric technologies that combine techniques for molecular and immunological diagnostics. One of its original technologies, MPCR-ULFA, which combines multiplex PCR amplification and Universal Lateral Flow Assay (ULFA) enables sensitive, specific, fast, affordable and simple nucleic acid tests that are especially suitable for applications in environments. of low resources.
In addition, we developed a rapid SARS-CoV-2 real-time RT-PCR kit that detects the new coronavirus, SARS-CoV-2 by using one-step real-time RT-PCR in a single tube (run time 50 min, limit of detection (LoD): 1 copy / L (5 copies/reaction)). We are currently developing the STI 12 MPCR-ULFA kit and will complete its development within the first half of next year.
Category sale
- Chemical products >> Chemical reagents
- Health and medicine >> Exam and test instrument
Keywords
Diagnostic, IVD, PCR, COVID-19, SARS-CoV-2, HPV, TB, STI, STD, MDx, Corna, In Vitro Diagnostic, In Vitro Diagnostic